Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: A narrow review

Macrophages are involved in the whole process of atherosclerosis, which is characterized by accumulation of lipid and inflammation. Presently, clinically used lipid-lowering drugs cannot completely retard the progress of atherosclerosis. Liver X receptor (LXR) plays a key role in regulation of lipid...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tong-Mei, Miao, Miao, Yu, Wen-Qian, Wang, Xue, Xia, Fang-Jie, Li, Yan-Jie, Guo, Shou-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018149/
https://www.ncbi.nlm.nih.gov/pubmed/36936982
http://dx.doi.org/10.3389/fmolb.2023.1147699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018149/
https://www.ncbi.nlm.nih.gov/pubmed/36936982
http://dx.doi.org/10.3389/fmolb.2023.1147699

Ejemplares similares